All animal subjects tolerated maximum dosing Once-per-day human intranasal dosing regimen determined for clinical evaluation SARASOTA, FL, Feb. 28, 2024.
Silo Pharma, Inc. (NASDAQ:SILO – Get Free Report) was the recipient of a large drop in short interest in December. As of December 15th, there was short interest totalling 55,800 shares, a drop of 28.7% from the November 30th total of 78,300 shares. Approximately 2.2% of the shares of the stock are sold short. Based […]